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Tuberculosis (TB) is a major killer, causing ≈1.4 million deaths worldwide annually (1), making it 
second only to coronavirus disease (COVID-19) as the 
biggest cause of infectious disease deaths in 2020 (2). 
In addition to the direct health effects of COVID-19, 
the secondary effects of the COVID-19 pandemic, 
including lockdowns, economic turmoil, healthcare 
worker illness and attrition, overwhelmed health fa-
cilities, and fear of healthcare facilities, might affect 
delivery of health services (3). Concerns have been 
raised that COVID-19 could adversely affect TB dis-
ease diagnosis, treatment, and prevention, reversing 
recent progress in improving TB case detection and 
reducing deaths, although protective measures used 
for COVID-19 also could reduce TB transmission 
(1,3,4). Initial modeling published in May 2020 sug-
gested that healthcare service disruption worldwide 
could lead to 6.3 million additional TB cases and 1.4 
million additional TB deaths from 2020 through 2025 
because of TB underdiagnosis and interruptions in 
TB treatment (5). Empirical data from settings with 
high TB burdens are urgently needed to examine the 
effects of COVID-19 on TB and to determine mitiga-
tion strategies (4).
According to the World Health Organization, 
Malawi is 1 of 30 countries that have high TB and 
HIV burdens (1). In Blantyre, in the southern re-
gion of Malawi, a citywide electronic TB register 
has been maintained in partnership by the Malawi 
Liverpool Wellcome Trust, Malawi National Tuber-
culosis Programme, and Blantyre District Health Of-
fi ce (6). We used these data to investigate the effects 
of COVID-19 on citywide TB case notifi cations. We 
hypothesized that the direct and indirect effects of 
the COVID-19 epidemic in Malawi would reduce TB 
case notifi cations and that effects might have been 
experienced disproportionately at different health 
system levels and by certain population groups, in-
cluding persons living with HIV. Our primary objec-
tive was to estimate the number of missed TB case 
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notifi	cations	 in	 April	 2020;	 notifi	cations	 recovered	 to	
near	prepandemic	numbers	by	December	2020.	How-
ever,	 333	 fewer	 cumulative	 TB	 notifi	cations	 were	 re-
ceived	than	anticipated.	Women	and	girls	were	aff	ected	
more	(30.7%	fewer	cases)	than	men	and	boys	(20.9%	










notifications. Our secondary objective was to deter-
mine whether missed notifications were affected by 
sex, health facility, or HIV status. Finally, to investi-
gate and explain the underlying causes of under noti-
fication of TB, we performed a qualitative study with 
TB officers, the cadre of healthcare workers who pro-
vide most TB services in Malawi.
Methods
Data Sources
To estimate population denominators for Blantyre 
District, we obtained age- and sex-specific back-
ground mortality rates and fertility rates from 2008–
2020 World Population Prospect data (7). We used 
the cohort-component method to combine these data 
into local estimates from the 2008 and 2018 Malawi 
national population censuses.
In Blantyre, TB officers working at all primary 
health centers and the city’s main hospital, Queen 
Elizabeth Central Hospital (QECH), record demo-
graphic and clinical characteristics of all TB patients 
who register for treatment by using an electronic case 
record form. Data collected includes date and clinic of 
registration, age, sex, HIV status, residential address, 
and TB characteristics, such as pulmonary versus ex-
tra-pulmonary TB and microbiological classification. 
Records are reconciled with the Ministry of Health 
National Tuberculosis Programme treatment regis-
ters every quarter. Each month, a randomly selected 
5% sample of people who registered for TB treatment 
undergoes home tracing for data validation purposes.
Statistical Modeling
To investigate the effects of COVID-19 on TB case 
notification in Blantyre, we conducted an interrupted 
time series analysis (8). The Malawi government de-
clared a state of emergency because of COVID-19 on 
March 23, 2020, and the first COVID-19 cases were 
diagnosed on April 2, 2020. We assumed that CO-
VID-19 restrictions and the government and public 
response to the emerging epidemic would cause both 
an immediate step change in TB case notifications 
and a slope change leading to different month-by-
month trends than those seen before COVID-19 (8). 
Using a negative binomial distribution to account for 
overdispersion, we modeled monthly counts of TB 
cases as a function of month, COVID-19, and month-
given-COVID-19, with an offset term to account for 
underlying population (Appendix, https://wwwnc.
cdc.gov/EID/article/27/7/21-0557-App1.pdf). We 
used TB notification data from June 2016, when the 
country began a universal test-and-treat program 
to provide antiretroviral therapy for persons with 
HIV and started using the Xpert MTB/RIF assay (9), 
which rapidly diagnoses Mycobacterium tuberculosis, 
the bacterium that causes TB disease, and rifampin 
resistance in <2 hours (10).
We estimated trends in TB case notification rates 
(CNRs) by using estimated Blantyre census popula-
tion denominators to convert model-fitted monthly 
numbers of notified cases to annualized equivalent 
cases per 100,000 population. We used the model to 
predict TB CNRs from April 2020 on under a coun-
terfactual situation in which COVID-19 had not oc-
curred and background trends from April 2016 and 
March 2020 continued linearly. We defined numbers 
of missed TB cases as the difference between the ob-
served numbers of notified cases and numbers ex-
pected under the counterfactual no–COVID-19 situ-
ation, acknowledging that some of the missed cases 
might be diagnosed later and thus be delayed rather 
than entirely missed. We estimated the 95% CI for 
the total number of missed TB cases through 1,000 
parametric bootstrap replications. We took observed 
cases as-is and predicted cases under the counterfac-
tual scenario from a normal distribution on the link 
scale with the mean equal to model prediction for 
given month under the counterfactual and SD equal 
to model SE for predictions for the given month un-
der the counterfactual scenario.
For the secondary objective, we modeled the dif-
ferential effect of COVID-19 on TB case notifications 
by sex, HIV status, and whether TB was diagnosed at 
the QECH or primary care level (Appendix). Because 
a small amount of data were missing for HIV status 
and sex, we performed multiple imputations using 
chained equations with predictive mean matching by 
using the mice package in R software (11).
All decisions about the expected effect model 
(i.e., a step and slope change), the date of change (i.e., 
April 2020), and the covariates in model 2 (i.e., age, 
sex, and primary care vs. QECH) were made a priori 
on the basis of knowledge about likely effects of CO-
VID-19 and covariates known to differentially affect 
access to TB healthcare (12). To assess the statistical 
significance of the change in TB notifications con-
current with COVID-19 epidemic in Malawi, we ex-
tracted residuals from a regression that did not model 
changes due to COVID-19. We compared the sum of 
the residuals for the 9 months during the COVID-19 
epidemic in Malawi, April–December 2020, with the 
distribution of this statistic from 1 million randomly 
permuted residuals. We also computed this statistic 





TB exhibits seasonality related to climate and weather 
conditions (13). Therefore, we performed a sensitivity 
analysis by adding seasonal effects to the interrupted 
time series model by using a harmonic term with 2 
peaks every 12 months.
Qualitative Analysis
During October 21–December 14, 2020, we conducted 
in-depth interviews with 12 TB officers from health-
care facilities in Blantyre, 2 from QECH and 10 from 
primary healthcare centers, to ascertain the main rea-
sons for changes in TB case notifications during the 
COVID-19 pandemic. A local social scientist with ex-
perience of qualitative interviewing conducted inter-
views in Chichewa, the local language. Data were re-
corded and simultaneously transcribed and translated 
to English. We developed a thematic framework from 
the initial 4 interviews, which we applied across all 
subsequent interviews. Coding and data analysis were 
done using NVIVO (QSR International, https://www.
qsrinternational.com). Interviews were continued until 
saturation of themes was reached. We did not inter-
view persons attending clinics to receive healthcare.
Ethics Approval
Participants provided oral consent for their data to 
be recorded in the enhanced surveillance dataset. A 
waiver of requirement for written consent was ap-
proved by London School of Hygiene and Tropical 
Medicine and College of Medicine, University of Ma-
lawi, both of which provided ethical approval for the 
Blantyre enhanced TB surveillance system and quali-
tative interviews. TB officer participants in the in-
depth interviews provided informed written consent.
Results
Interrupted Time Series
During June 2016–December 2020, a total of 10,274 
people starting TB treatment were notified in Blantyre. 
During June 2016–March 2020 (i.e., before COVID-19), 
annualized Blantyre TB CNRs fell by ≈1% per month, 
reaching a peak of 405 cases/100,000 persons in Novem-
ber 2016 and declining to 137 cases/100,000 persons in 
October 2019. A total of 9,199 TB cases were notified in 
Blantyre during the pre–COVID-19 period (June 2016 
to December 2020), 3,561 among women and girls and 
5,611 in men and boys; 27 cases were missing data on 
sex. Persons living with HIV represented 5,820 (63.3%) 
TB notifications and 3,279 (35.6%) HIV-negative persons 
were among notified TB cases; 100 TB cases had miss-
ing data or unknown HIV status. TB notifications were 
split almost evenly between QECH (4,889 notifications; 
53.1%) and primary health facilities (4,310 notifications; 
46.9%). Children <14 years of age comprised 920 (10%) 
notifications. The median age among adults with diag-
nosed TB was 35 (interquartile range [IQR] 28–44) years 
for women and 37 (IQR 30–45) years for men.
The declaration of a national COVID-19 disaster 
led to an abrupt 35.9% (95% CI 22.1%–47.3%) decline 
in TB notifications in April 2020 (Figure 1). However, 
subsequent TB notifications increased at a rate of 4.40% 
(95% CI 0.59%–8.36%) per month. The effect of the ini-
tial decline at the start of the COVID-19 pandemic was 
that observed Blantyre TB annualized CNRs pre–CO-
VID-19, in March 2020, were 240 cases/100,000 persons 
and rates after the COVID-19 disaster declaration were 
152 cases/100,000 persons in April 2020. By compari-
son, the predicted April CNR in the counterfactual sce-
nario without COVID-19 was 230 cases/100,000 person-
years. However, by November 2020, observed Blantyre 
TB CNRs were 205 cases/100,000 person-years and De-
cember 2020 rates were 156 cases/100,000 person-years, 
compared with a predicted CNR of 213 cases/100,000 
person-years in November and 211 cases/100,000 per-
son-years in December in the counterfactual scenario.
During April–December 2020, a total of 1,075 TB 
cases were notified in Blantyre, equivalent to 196 cas-
es/100,000 person-years (Table 1). Under the counter-
factual situation of no COVID-19 epidemic, we would 
expect 1,408 (95% CI 1,366–1,451) TB cases would 
have been notified, equivalent to annualized case 
notification rate of 221 cases/100,000 person-years. 
Therefore, we estimate that the COVID-19 epidemic 
directly and indirectly led to 333 (95% CI 291–376) 
fewer TB notifications, a 23.7% (95% CI 21.4%–26.0%) 
reduction in TB notifications.
As a secondary objective, we modeled which popu-
lation groups were most affected by disruption to TB 
services (Figure 2). This model incorporated sex, HIV 
status, and healthcare facility (QECH vs. primary care 
clinics) and estimated that 352 (95% CI 319–385) TB 
cases were missed during April–December 2020. Men 
and boys accounted for a slightly larger number of 
missed TB diagnoses with 183 (95% CI 158–209) missed 
cases compared with 170 (95% CI 151–188) missed 
cases among women and girls. However, women and 
girls had a larger proportional decline, 30.7% (95% CI 
28.4%–33.0%) than did men and boys, 20.9% (95% CI 
18.5%–23.3%). Notifications at primary healthcare cen-
ters also were disproportionately reduced compared 
with hospital notifications, as were notifications for 
HIV-negative persons compared with those living with 
HIV (Table 2). The nonoverlapping confidence inter-
vals for these groups indicated statistically significant 
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differences in effects of COVID-19 by gender, HIV sta-
tus, and healthcare setting.
The drop in TB notifications during April–Decem-
ber 2020 was greater than that for any other 9-month 
period observed, and the sum of the residuals during 
this period was more negative than expected by ran-
dom chance (p = 0.004). The sum of residuals in other 
9-month periods was significantly more negative than 
anticipated from random resampling (p<0.05), indicat-
ing a unique statistically significant drop in cases during 
April–December 2020. Sensitivity analysis around sea-
sonality of TB did not materially affect the conclusions.
Qualitative Results
Of the 12 in-depth interviews with healthcare provid-
ers, 9 participants were female and 3 were male; ages 
were 34–53 years. Most (10/12) participants had sec-
ondary-level education. Themes that emerged from 
the in-depth interviews related to both an overall re-
duction in persons attending health facilities and to 
TB-specific issues.
Reduced Attendance at Healthcare Facilities
In addition to reduced attendance at healthcare fa-
cilities among the general public from fear of being 
infected with COVID-19, participants mentioned that 
several healthcare workers tested positive for CO-
VID-19 during the epidemic (Table 2). The facility-
based COVID-19 outbreaks led to temporary closures 
for disinfection. Facility closures not only affected 
the number of persons attending the health facilities 































Model	1     
 Overall 1,075 1,408	(1,366–1,451) 333	(291–376) 23.7	(21.4–26.0) 
Model	2     
 Sex     
  M 692 875	(848–901) 183	(156–209) 20.9	(18.5–23.3) 
  F 383 553	(534–571) 170	(151–188) 30.7	(28.4–33.0) 
 Primary	health	centers 488 761	(737–785) 273	(249–297) 35.9	(33.9–37.9) 
 Queen	Elizabeth	Central	Hospital 587 666	(645–688) 79	(58–101) 11.9	(9.10–14.7) 
 HIV	status     
  HIV-positive 660 820	(796–845) 160	(136–185) 19.6	(17.2–21.9) 




infection at healthcare facilities and, in 1 instance, ru-
mors that the clinic was closed for a longer period 
than it was (Table 2). Finally, health facility worker 
strikes and sit-ins over risk allowance payments and 
lack of personal protective equipment (PPE) also re-
sulted in temporary closures of facilities (Table 2).
Effects of COVID-19 Prevention Measures on  
Healthcare Access
Government COVID-19 prevention measures that 
required use of facemasks and social distancing also 
were reported to have contributed to reduced access 
to health services. Mandatory use of face masks at 
health facilities was introduced during the epidemic, 
but TB officers cited the inability to afford a mask and 
the feeling that masks “suffocate them” as reasons pa-
tients did not want to wear masks (Table 2). Patients 
who tried to attend facilities without having a mask 
were sent away (meaning that they were not seen by a 
healthcare worker) and often did not return (Table 2). 
Public transportation in Blantyre also had a limit on 
vehicle capacity, which led to doubled transport costs 
and limited clinic access (Table 2).
TB-Specific Issues
Because TB and COVID-19 both have symptoms of 
cough and fever, TB officers reported issues around 
TB testing. First, persons with fever and cough report-
edly were afraid of being tested for COVID-19 if they 
went to healthcare facilities. TB officers said patients 
were more afraid of COVID-19 than TB because they 
knew that TB could be cured and that patients with 
COVID-19 might need to be placed under facility iso-
lation (Table 2). The similarity of symptoms also led to 
persons who normally would have been tested for TB 
being turned away from healthcare facilities and told 
to go home and call the COVID-19 help line (Table 2).
Reduced Healthcare Worker Capacity
TB officers also spoke of their own fear of contract-
ing COVID-19 from presumptive TB patients. TB of-







symptomatic persons, including interacting less di-
rectly and not supervising sputum collection as closely 
(Table 2). In addition, many TB officers reported that 
the lack of PPE in health facilities forced them to tem-
porarily stop conducting TB tests or supervising spu-
tum collection at all. For those patients who did submit 
sputum, results could be delayed because, as a TB offi-
cer reported, laboratory staff “were taught that sputum 
has the highest concentration of COVID-19” (Table 2).
Discussion
In addition to directly causing millions of deaths, 
the COVID-19 pandemic has directly and indirectly 
affected delivery of health services globally (14). In 
our analysis of the effects of the COVID-19 pandem-
ic on TB notifications in Blantyre, Malawi, we found 
a substantial immediate decline in TB case notifi-
cations concurrent with the start of the COVID-19 




Theme,	quote	no. Participant	no.,	sex Quote 
Fear	of	COVID-19	contagion	at	health	facilities 
 Q1 02,	F “People were afraid of getting infected if they come to the facility.” 
 Q2 09,	F “… they were afraid saying that if the workers are found with COVID, so if we go there 
they will infect us.” 
COVID-19	related	health	facility	closures  
 Q3 03,	F “…they were told that the clinic had been shut down and people are not being assisted… 
which	means	people	were	just	staying	in	their	homes	and	the	TB	was	just	being	spread	
amongst them.” 
 Q4 02,	F “Our facility wasn’t closed, but there was a certain week that we were just going but we 
were	not	working	because	there	was	no	PPE,	so	people	were	afraid.	There	were	no	
gloves,	no	masks	how	were	we	going	to	work?	So	a	sit-in happened.” 
 Q5 05,	F “Yes we had	a	strike	at	this	hospital	and	the	strike	occurred	in	all	health	centres.	The	
reason	behind	the	strike	was	that	COVID-19 was at its peak but we didn’t have PPE	
which was putting us at risk.” 
 Q6 07,	M “The first strike was against shortage of PPEs and the	second	strike	was	organized	by	
Interns	who	were	complaining	that	they	are	making	them	work	on	this	dangerous	
disease	of	COVID-19 yet they are not being employed… And the other strike was about 
risk allowance.” 
Effects	of	COVID-19	prevention	measures	on	healthcare	access 
 Q7 04,	F “…then government announced that wearing of mask is mandatory some people who 
couldn’t manage wear the mask were making a decision of not going to the hospital 
instead,	some	were	complaining	that	they	suffocate	in	a mask.” 
 Q8 08,	F “…all patients should be wearing masks when coming here but some patients were 
ignoring	and	when	we	send	them	back	to	go	and	get	a	mask	some	patients	were	ending	
up not coming back.” 
 Q9 08,	F “Some people travel from far communities	to	come	here	and	the	increase	in	transport	
fare also influenced some people to fail to come to the hospital.” 
Similarity	of	TB	and	COVID-19	symptoms	leading	to	reduced	access	to	TB	care 
 Q10 02,	F “… sometimes they think that if they test positive [for COVID-19],	people	will	discriminate	
them, they have fear of unknown. So during this period people weren’t coming to say I 
have	a	cough,	test	me,	they	were	just	staying	at	home	buying	Bactrim	and	drinking it at 
home.” 
 Q11 06,	F “the signs and symptoms of COVID-19	and	TB	were	somehow	similar	so	because	the	
signs	were	similar	people	were	scared	to	come	to	the	hospital	because	they	were	
assuming	that	instead	of	testing	them	for	TB	we	will	test	them	for	COVID-19” 
 Q12 07,	M “They were communicating that if a person has fever then that is a sign of COVID-19	
and	that	particular	person	is	required	to	go	into	isolation	so	people	were	afraid	to	come	
to	the	hospital	when	they	have	fever	because	of	the	messages	that	they	may	be	isolated	
with their families.” 
 Q13 01,	M “… they were expecting that someone who has COVID-19	coughs	and	sneezes	
severely,	and	has	fever	and	headaches,	so	when	they	ask	about	those,	the	same	things	
that	a	TB	patient	presents,	that	was	when	those	people	were	being	sent	back	to	go	
home	and	call	the	COVID-19 help line.” 
Reduced	healthcare	worker	capacity	to	support	TB	testing 
 Q14 05,	F “… we were no longer asking many questions once the person tells us that she has dry 
cough	we	were	running away from that person… Because if the person has dry cough 
the	first	thing	that	we	were	thinking	of	is	COVID-19.” 
 Q15 11,	F “I was scared because it was difficult to know if the patient is coughing because of TB or 
COVID-19.” 
 Q16 01,	M “… in the laboratory… the ones that are involved in the testing, they were refusing to 
handle	sputum	because	they	were	taught	that	sputum	has	the	highest	concentration	of	




with initial reports on COVID-19 effects on HIV and 
TB diagnosis and care from other settings (15–22). 
However, we show that, after an initial decline, TB 
CNRs increased and reached near prepandemic 
levels within 9 months. Overall, we estimate that 
333 fewer cases of TB were notified, equivalent to 
39 cases/100,000 persons, during April–December 
2020 than would have been expected in the absence 
of the COVID-19 epidemic. For the affected persons, 
the missed or delayed diagnoses likely will have se-
vere consequences, and for public health programs 
the consequences might hinder progress toward TB 
elimination. The reduction in TB case notifications 
also could be indicative of more general disruption 
of a range of primary healthcare services.
To put these results into context, Malawi has high 
HIV and TB burdens. Estimated prevalence of TB in 
urban Malawi was 988 cases/100,000 persons at the 
last national survey in 2013 (4). TB in Malawi is de-
clining in response to concerted efforts from the na-
tional and district TB and the HIV programs. In June 
2016, Malawi introduced a test-and-treat program for 
HIV, which involved starting antiretroviral therapy 
for persons who had positive HIV tests regardless of 
CD4 cell count. Malawi is coming close to achieving 
United Nations AIDS/HIV 90-90-90 goals (23). How-
ever, TB remains one of the leading causes of death 
and years of life lost in Malawi (24).
We hypothesize that the major reason for the 
drop in TB notifications during the COVID-19 pan-
demic is that persons with true TB disease had their 
TB diagnosis missed or at least delayed. This hy-
pothesis is consistent with data from our qualita-
tive interviews with TB officers, who noted that, in 
the immediate period after the Malawi COVID-19 
epidemic began, access to health facilities was ex-
tremely challenging. Alternative explanations are 
that persons with diagnosed TB started on treat-
ment, but their cases were not notified to the na-
tional program, or that the true incidence of TB 
declined. However, we consider these explanations 
unlikely. TB treatment cannot be accessed in Mala-
wi outside of TB registration centers, and our elec-
tronic TB surveillance system is cross-referenced 
with paper ledgers that confirm the same trends 
in notifications. Reduced incidence of other respi-
ratory pathogens, notably influenza, has resulted 
from the nonpharmaceutical interventions for CO-
VID-19, which possibly also resulted in a decline in 
TB transmission. However, the prolonged interval 
between infection and onset of symptoms for TB 
makes an immediate effect on notifications in <3 
months implausible, particularly because Malawi 
has had less stringent COVID-19 prevention mea-
sures than many other countries.
Our qualitative interviews indicate that, in addi-
tion to general restrictions on healthcare access during 
the COVID-19 epidemic, TB testing and notifications 
particularly were affected because of the similarity 
in clinical presentation of TB and COVID-19. The TB 
officers considered that persons with TB symptoms 
were less likely to attend facilities for fear of a CO-
VID-19 diagnosis and possible consequences, such 
as isolation. In addition, TB officers believed that at 
least some persons with possible TB who went to 
healthcare facilities were turned away and directed 
to COVID-19–specific services where they would be 
unlikely to be assessed for TB. In countries with high 
TB burdens, alignment of COVID-19 and TB diagno-
sis, prevention, and care will likely lead to improved 
outcomes for both diseases.
Women and girls had disproportionately higher 
reductions in case notifications than men and boys, 
as did HIV-negative compared with HIV-positive pa-
tients and notifications from primary care clinics com-
pared with the central hospital. We hypothesize that 
women and girls faced greater barriers to accessing 
healthcare during COVID-19 than men and boys be-
cause of greater requirements of women to stay home 
to school children; social gender norms, meaning that 
men were more likely to disregard COVID-19 public 
health restrictions; and perhaps economic require-
ments for men leave the house to work, meaning men 
could more easily continue to access TB services (25).
Primary healthcare centers were more affect-
ed than QECH, both in terms of initial step change 
(drop in TB cases notified at the start of COVID-19) 
and with slower recovery in the period after the ini-
tial phase of COVID-19 epidemic in Malawi. Reasons 
for the difference in reporting rates could include 
QECH being prioritized for PPE, thus remaining 
more functional than healthcare centers; in addition, 
patients with TB diagnosed at QECH tend to have 
more severe illness and potentially were unable to 
delay seeking healthcare.
TB cases among HIV-negative persons declined 
more than among persons living with HIV, which also 
could be associated with site of TB diagnosis. QECH 
has the largest number of HIV-positive persons regis-
tered for antiretroviral therapy in the city, and so per-
sons living with HIV may have accessed TB services 
through the ART clinic. Alternatively, persons living 
with HIV can have more severe TB symptoms and be 
less able to defer healthcare seeking.
Limitations to our study include uncertainty 
around the counterfactual conditions; during June 
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2016–March 2020, TB case notifications were declin-
ing in Blantyre, and for the counterfactual condition, 
no COVID-19 scenario we modeled TB notifications 
as continuing to decline at the same rate. Since De-
cember 2020, Malawi has had a second wave of COV-
ID-19. Our electronic enhanced surveillance data are 
entered in real time, but data are monitored and veri-
fied on a quarterly basis, so we do not yet have infor-
mation on the effects of the second wave of COVID-19 
in Malawi. Finally, we only interviewed healthcare 
workers; we did not directly capture perspectives of 
patients about their difficulties accessing healthcare.
Malawi is fortunate to have well-functioning TB 
and HIV programs that are more resilient to COV-
ID-19 than programs in other countries. Malawi did 
not introduce any substantial restrictions on popu-
lation movement and gathering due to COVID-19, 
so no legal restrictions hindered travel to TB clinics. 
Therefore, our data are not necessarily generalizable 
to other settings in southern Africa or elsewhere.
In conclusion, the effects of missed or delayed TB 
diagnoses likely will be severe for affected persons 
and households. However, the initial COVID-19–re-
lated decline in TB case notification was not sustained, 
and the Malawi National Tuberculosis Programme 
had a relatively quick recovery after the first wave of 
COVID-19. We observed a shorter period of disrup-
tion than earlier modeling of COVID-19 effects on TB 
assumed (5). COVID-19 or TB diagnosis, treatment, 
care, and public health measures should not be con-
sidered in isolation. Rather, public health and health-
care officials should seek opportunities to combine 
resources to tackle both COVID-19 and TB. Through 
improved infection prevention and control at health 
facilities, strengthened laboratory infrastructure, 
and community engagement to address stigma and 
provide sources of information about both diseases, 
communities can create a setting of universal health 
coverage.
Data and code to recreate analyses are freely available at 
https://github.com/rachaelmburke/tbcovidblantyre.
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EID Podcast
Telework during  
Epidemic  
Respiratory Illness
Visit our website to listen:
 https://go.usa.gov/xfcmN
The COVID-19 pandemic has caused us 
to reevaluate what “work” should look like. 
Across the world, people have converted 
closets to offices, kitchen tables to desks, 
and curtains to videoconference back-
grounds. Many employees cannot help but 
wonder if these changes will become a 
new normal.
During outbreaks of influenza, corona-
viruses, and other respiratory diseases, 
telework is a tool to promote social dis-
tancing and prevent the spread of disease. 
As more people telework than ever before, 
employers are considering the ramifica-
tions of remote work on employees’ use of 
sick days, paid leave, and attendance. 
In this EID podcast, Dr. Faruque Ahmed, 
an epidemiologist at CDC, discusses the 
economic impact of telework.
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Effects of Coronavirus Disease Pandemic 
on Tuberculosis Notifications, Malawi 
Appendix  
Models 
We used 2 models to estimate effects of coronavirus disease (COVID-19) on rates of 
tuberculosis (TB) case notifications in Blantyre, Malawi. One model estimates the effects of 
COVID-19 on TB case notifications, the other estimates differential effects of COVID-19 on TB 
case notifications by various factors. 
Model 1 
To estimate effects of COVID-19 on Blantyre TB case notification rates we used the 
following formula: 
log(cases) = α + β1(covid) + β2(month) + β3(covid × month.since.covid) + log(population) 
In this formula, cases are the expected numbers of notified TB cases per month, ⍺ is 
the intercept, covid is the indicator variable for the period before or after introduction of COVID-
19 restrictions (before or after April 1, 2020), month is the indicator for month from June 2016, 
month.since.covid is the number of months after April 1, 2020, and population is the monthly 
updated population denominator for Blantyre District. 
Model 2 
To estimate differential effects of COVID-19 on the number of TB cases notified by sex, 
HIV status, and whether TB was diagnosed at a primary care versus central hospital, we used the 
following formula: 
log(cases) = α + β1(sexmale) + β2(hivpositive) + β3(facqech) + ∑ 𝛽𝛽𝑖𝑖𝑖𝑖𝑖𝑖(0)𝑖𝑖𝑖𝑖𝑖𝑖 (sexi × hivj × fack) month + 
covid × ∑ 𝛽𝛽𝑖𝑖𝑖𝑖𝑖𝑖(1)𝑖𝑖𝑖𝑖𝑖𝑖 (sexi × hivj × fack)month.since.covid 
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In this formula, cases indicates the expected numbers of notified TB cases per month, ⍺ is 
the intercept, covid is the indicator variable for the period before or after introduction of COVID-
19 restrictions (before or after April 1, 2020), month is the indicator for month from June 2016, 
month.since.covid is the number of months after April 1, 2020, sexi is the indicator for the sex of 
a person (𝑖𝑖 = positive, ∈ = negative]), hivj is the indicator for HIV status of person (𝑗𝑗 = male, ∈ =
 female]), fack is the indicator for the facility where TB was diagnosed (𝑘𝑘 = hc, ∈ = qech] in 
which hc indicates a primary healthcare center and qech indicates Queen Elizabeth Central 
Hospital). 
